13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000899140-25-000321
Total Value
$322.9M
Positions
8
Other Managers
0
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INNOVIVA INC | INVA | 7,277,000 | $126.3M | 39.11% |
| 2 | IRONWOOD PHARMACEUTICALS INC | IRWD | 16,390,000 | $72.6M | 22.49% |
| 3 | NEUROCRINE BIOSCIENCES INC | NBIX | 309,116 | $42.2M | 13.07% |
| 4 | CYTOKINETICS INC | CYTK | 833,799 | $39.2M | 12.15% |
| 5 | GILEAD SCIENCES INC | GILD | 262,080 | $24.2M | 7.50% |
| 6 | AMARIN CORP PLC | AMRN | 24,850,623 | $12.1M | 3.73% |
| 7 | LANTHEUS HLDGS INC | LNTH | 63,000 | $5.6M | 1.75% |
| 8 | VOR BIOPHARMA INC | VOR | 618,000 | $685,980 | 0.21% |